Pantoprazole: Clinical Trials

19 trials of Pantoprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 5 recruiting, 2 unknown, 1 terminated. 19 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 219Completed 11, Recruiting 5, Unknown 2, Terminated 1
Phase 34Completed 3, Recruiting 1
Phase 11Recruiting 1

Follow Pantoprazole: new trials by email Literature Review of Pantoprazole trials Research Report on Pantoprazole

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)
Protonix (Pantoprazole) 40 mg q 12 hrs for 3 days, Pepcid (Famotidine) 20 mg q 12 hrs for 3 days - Acute Kidney Injury
Phase 2RecruitingThe University of Texas Health Science Center, Houston4002025-01-242025-05-14
PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease
Omeprazole 40 mg IV, pantoprazole 40 mg iv - Morbidity
Phase 2RecruitingUniversidad Autonoma de Nuevo Leon1202024-10-202026-11-18
Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients
Protonix (Pantoprazole) 40 mg q 12 hrs for 2 days, Protonix (pantoprazole) 40 mg q 24 hrs for 2 days - Acute Kidney Injury
Phase 2 / Phase 3RecruitingThe University of Texas Health Science Center, Houston1002024-09-072026-02-19
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
BMS-986470, Placebo, Famotidine - Anemia, Sickle Cell, Healthy Volunteers
Phase 1 / Phase 2RecruitingBristol-Myers Squibb2242024-07-172026-08-18
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Pantoprazole, Famotidine - Acute Kidney Injury
Phase 2CompletedThe University of Texas Health Science Center, Houston1002024-01-102026-03-10
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
pantoprazole, Placebo - Postoperative Nausea and Vomiting
Phase 2RecruitingUnited States Naval Medical Center, Portsmouth1322022-08-262025-05-21
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
Placebo, Pantoprazole - Pancreatic Cancer, Pancreas Cancer
Phase 2TerminatedWashington University School of Medicine562022-04-212025-05-06
Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function
pantoprazole - Proton Pump Inhibitor Allergy
Phase 2UnknownAssiut University2002019-12-012019-07-17
Effect of Proton Pump Inhibitor of Daily Use for One Month on Kidney Function Test
Pantoprazole 40mg - Proton Pump Inhibitor Allergy
Phase 2UnknownAssiut University2002019-11-012019-07-17
Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy
Pantoprazole 40mg, Placebo - Oncology, Breast Cancer
Phase 2CompletedUniversity of Auckland, New Zealand1602019-06-102022-05-25
Aspirin in Young Psychotic Patients
Aspirin, Placebo, Pantoprazole - Psychosis, Acute Psychosis
Phase 2 / Phase 3CompletedClinic for Psychiatric Disorders, Dr Laza Lazarevic602017-07-202024-09-23
Histamine Glutamate Antagonism in Stroke
Diphenhydramine, Pantoprazole, Famotidine - Acute Cerebrovascular Accident, Cerebral Edema
Phase 2CompletedUniversity of Florida32014-12-012015-12-15
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Pantoprazole, High-dose methotrexate infusion duration - Osteosarcoma, Nephrotoxicity
Phase 2CompletedChildren's Hospital of Philadelphia132013-04-012020-03-16
Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer
Pantoprazole - Prostate Cancer
Phase 2CompletedUniversity Health Network, Toronto212013-01-012021-03-23
Pantoprazole on Insulin Secretion in Diabetes
Pantoprazole, placebo - Type 2 Diabetes
Phase 2 / Phase 3CompletedCoordinación de Investigación en Salud, Mexico142012-01-012014-02-21
Incretin Effect and Use After Clinical Islet Transplantation
Pantoprazole, Sitagliptin - Type 1 Diabetes
Phase 2CompletedUniversity of Alberta82008-10-012015-06-18
Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.
Pantoprazole, placebo - Gastroesophageal Reflux Disease
Phase 2 / Phase 3CompletedSouthern Arizona VA Health Care System402008-04-012010-08-19
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Pantoprazole - Peptic Ulcer Hemorrhage
Phase 2CompletedWyeth is now a wholly owned subsidiary of Pfizer122000-11-012013-02-08
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
Pantoprazole, Omeprazole - Gastrinoma, Zollinger Ellison Syndrome
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1983-02-032017-07-02

Conditions studied

Acute Kidney Injury (3)  ·  Neoplasms (2)  ·  Anemia, Sickle Cell (1)  ·  Brain Edema (1)  ·  Breast Neoplasms (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Duodenal Neoplasms (1)  ·  Esophagitis (1)  ·  Gastrinoma (1)  ·  Gastroesophageal Reflux (1)  ·  Heartburn (1)  ·  Hemorrhage (1)  ·  Insulin Resistance (1)

Sponsors

The University of Texas Health Science Center, Houston (3)  ·  Assiut University (2)  ·  Bristol-Myers Squibb (1)  ·  Children's Hospital of Philadelphia (1)  ·  Clinic for Psychiatric Disorders, Dr Laza Lazarevic (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Southern Arizona VA Health Care System (1)  ·  United States Naval Medical Center, Portsmouth (1)  ·  Universidad Autonoma de Nuevo Leon (1)  ·  University Health Network, Toronto (1)  ·  University of Alberta (1)  ·  University of Auckland, New Zealand (1)  ·  University of Florida (1)  ·  Washington University School of Medicine (1)

Countries

United States (11)  ·  Canada (3)  ·  Mexico (2)  ·  France (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Serbia (1)  ·  United Kingdom (1)

Top investigators

Yafen Liang, MD (3)  ·  Casey Timmerman, DO (1)  ·  Frank M Balis, MD (1)  ·  Manuel Gonzalez, PhD (1)  ·  Natasha Leigh-Matijakovich, M.D. (1)  ·  Navin Wewala, MBChB FRACP (1)  ·  Peter Senior, MD, PhD (1)  ·  Ricard Isaacs, MBChB FRACP (1)  ·  Ronnie Fass, MD (1)  ·  Vishnumurthy S Hedna, MD (1)

Results publications

PMID 25704601, PMID 27087519, PMID 29445029, PMID 33677616, PMID 40394328

NIH funding

2023 (1)